Citation Impact
Citing Papers
Induction of Broadly Neutralizing H1N1 Influenza Antibodies by Vaccination
2010 Science
Biogenesis of Influenza A Virus Hemagglutinin Cross-Protective Stem Epitopes
2014 StandoutNobel
Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge
2017 StandoutNobel
Improving pandemic H5N1 influenza vaccines by combining different vaccine platforms
2014
Lipid-nanoparticle-encapsulated mRNA vaccines induce protective memory CD8 T cells against a lethal viral infection
2021 StandoutNobel
Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection
2012
Virulence determinants of pandemic influenza viruses
2011
Messenger RNA-Based Vaccines Against Infectious Diseases
2020 StandoutNobel
Needle-free influenza vaccination
2010
Syndemics and the biosocial conception of health
2017 Standout
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Context-Specific Target Definition in Influenza A Virus Hemagglutinin-Glycan Receptor Interactions
2009
Effect of Immunosuppression on T-Helper 2 and B-Cell Responses to Influenza Vaccination
2015 StandoutNobel
mRNA-based therapeutics — developing a new class of drugs
2014 StandoutNobel
What is self-rated health and why does it predict mortality? Towards a unified conceptual model
2009 Standout
Prospects for prophylactic and therapeutic vaccines against the hepatitis C viruses
2010 StandoutNobel
Slicing the health service cake: the Islington study
2002
Vaccination with Messenger RNA: A Promising Alternative to DNA Vaccination
2020 StandoutNobel
Changes in self-rated health, disability and contact with services in a very elderly cohort: a 6-year follow-up study
1998
Transmissibility and transmission of respiratory viruses
2021
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes
2015 StandoutNobel
A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice
2020 StandoutNobel
Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin
2007
Vaccine adjuvants – understanding molecular mechanisms to improve vaccines
2014 StandoutNobel
Interferons and viruses: an evolutionary arms race of molecular interactions
2015 StandoutNobel
Glycotherapy: New Advances Inspire a Reemergence of Glycans in Medicine
2013 StandoutNobel
mRNA transcript therapy
2014 StandoutNobel
Cost of community care for older people
1997
Nucleoside Modified mRNA Vaccines for Infectious Diseases
2016 StandoutNobel
Microneedles for drug and vaccine delivery
2012 Standout
Formal and informal care for people with dementia: Factors associated with service receipt
2002
Mouse STAT2 Restricts Early Dengue Virus Replication
2010
Cornerstones of CRISPR–Cas in drug discovery and therapy
2016 StandoutNobel
Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies
2018 StandoutNobel
Measuring the Adjuvant Activity of RNA Vaccines
2016 StandoutNobel
Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective
2020 Standout
SARS-CoV-2 vaccines in development
2020 StandoutNature
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America
2019 Standout
Nucleoside-Modified mRNA-Based Influenza Vaccines Circumvent Problems Associated with H3N2 Vaccine Strain Egg Adaptation
2022 StandoutNobel
2012 Alzheimer's disease facts and figures Alzheimer's Association ∗
2012 Standout
Corticosteroids as adjunctive therapy in the treatment of influenza
2019
Disease Tolerance as a Defense Strategy
2012 StandoutScience
The Ferret Model for Influenza
2009
Corticosteroids as adjunctive therapy in the treatment of influenza
2016
Covid-19 in Critically Ill Patients in the Seattle Region — Case Series
2020 Standout
New Kids on the Block: RNA-Based Influenza Virus Vaccines
2018
Quantitative aerobiologic analysis of an influenza human challenge‐transmission trial
2020
Airborne transmission of respiratory viruses
2021 StandoutScience
Corticosteroids as Adjunctive Therapy in the Treatment of Influenza: An Updated Cochrane Systematic Review and Meta-analysis
2019
Exploring the Interrelationship between COVID-19 Phobia, Work–Family Conflict, Family–Work Conflict, and Life Satisfaction among School Administrators for Advancing Sustainable Management
2021 Standout
Works of Alex Mann being referenced
The Gospel Oak project 1987-1990: provision and use of community services.
1994
Interfering vaccine (defective interfering influenza A virus) protects ferrets from influenza, and allows them to develop solid immunity to reinfection
2006
Minimal transmission in an influenza A (H3N2) human challenge-transmission model within a controlled exposure environment
2020
Preclinical Evaluation of a Replication-Deficient Intranasal ΔNS1 H5N1 Influenza Vaccine
2009
Minimal Transmission in an Influenza A (H3N2) Human Challenge-Transmission Model with Exposure Events in a Controlled Environment
2019
Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model
2016
Differential evolution of peripheral cytokine levels in symptomatic and asymptomatic responses to experimental influenza virus challenge
2015
Animal models in influenza vaccine testing
2008